Glucotrack to participate in the q3 virtual investor summit

Rutherford, n.j., sept. 11, 2025 (globe newswire) -- glucotrack, inc. (nasdaq: gctk) (“glucotrack” or the “company”), a medical technology company focused on the design, development, and commercialization of novel technologies for people with diabetes, today announced that management will present and participate in one-on-one meetings with investors at the q3 virtual investor summit, being held on september 16-17, 2025.
GCTK Ratings Summary
GCTK Quant Ranking